Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

 

In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients.

Additional Reading:

  • Solomkin JS, Gardovskis J, Lawrence K, et al. IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections. Clin Infect Dis. 2019;69(6):921-929. https://doi.org/10.1093/cid/ciy1029

 

Joseph Solomkin, MD, is a Professor of Surgery Emeritus at the University of Cincinnati in Ohio. He is also a consultant for Tetraphase, the pharmaceutical company that produces eravacycline.

Submit Feedback

Name